Susanna Majala
Expertese
- Chromogranin a and pancreatic polypeptide are not suitable for the screening of pancreatic neuroendocrine tumors in MEN1 - a long-term follow-up study (2025)
- Endocrine
- Prediction of the Aggressiveness of the Pancreatic Neuroendocrine Neoplasms Using Positron Emission Tomography and Immunohistochemical Biomarkers (2025) Majala, Tiina
- Predictors of long-term survival for patients with pancreatic neuroendocrine neoplasm in FinPanNET: nationwide biobank study with histopathological re-evaluation (2025)
- British Journal of Surgery
- Pancreatic imaging in MEN1-comparison of conventional and somatostatin receptor positron emission tomography/computed tomography imaging in real-life setting (2023)
- European Journal of Endocrinology
- Correlation of Somatostatin Receptor 1–5 Expression, [68Ga]Ga-DOTANOC, [18F]F-FDG PET/CT and Clinical Outcome in a Prospective Cohort of Pancreatic Neuroendocrine Neoplasms (2022)
- Cancers
- Prediction of the aggressiveness of non-functional pancreatic neuroendocrine tumors based on the dual-tracer PET/CT (2019)
- EJNMMI Research